Medtronic Lawsuit

Recently Medtronic has announced that it will release a new product worldwide.  This time the device is what’s called the Endurant stent graft, which is set to be releases in mid-July.  It will be used by physicians to treat abdominal aortic aneurysms through endovascular treatment methods. 

The European regulatory board approved the device last week and the first implant trials have already taken place in the United States.  The Food and Drug Administration (FDA) approved the piece technology last month through an “investigational device exemption.”

Abdominal Aortic Aneurysm is a dangerous bulge or weakness in the body’s main artery that risks rupturing or bursting, which can result in fatal consequences.  The device is supposed to enhance comfortability and trackability for an overall pleasant experience.

Given Medtronic’s history, be careful if you are anticipating receiving this treatment.  All forms of technology have a chance of failing and sometimes those failures can be avoided.  In the interest of life preservation, take some time to meet with a Medtronic lawsuit attorney of the Williams Kherkher lawfirm to discuss your options in case the worst were to happen.  They are standing by at 866.950.9000.